Of patients with no draining tunnels at baseline, 87.8% still had none at one year, and 90.8% at three years* – indicating sustained symptom relief in these lesions Clinically meaningful improvements ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to pr ...

Q3 2025 Earnings Call Transcript October 30, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.75 ...

Completed enrollment in Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa; topline data expected mid-2026Appointed Kevin Lind to Board of DirectorsExpanded leadership team ...

“While medical treatments and surgeries are essential, palliative care ensures that no one has to face a life-changing diagnosis alone. It is holistically centred on offering hope, compassion and ...

They found that the proportion of patients younger than 50 admitted to the hospital with severe diverticulitis increased by ...

HS (hidradenitis suppurativa) affects thousands – often silently – but it can cause long-term pain, scarring and distress.

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: While most estimates place the ...

A hidradenitis suppurativa expert doctor shares effective strategies for care, and where HS research is headed. ...